The pharma company's net profit soared 77.1% year-on-year (YoY) in Q3FY25 to ₹82.9 crore from ₹46.8 crore in the same period last year. Revenue from operations surged 39.8% to ₹307.2 crore, up from ...

Ramesh Swaminathan, Global CFO of pharmaceutical company Lupin, warns that Trump tariffs could deny many in the U.S. access ...

Natco Pharma tanked 17.91% to Rs 998.70 after the company's consolidated net profit declined 37.75% to Rs 132.4 crore on 37.41% drop in revenue from operations to Rs 474.8 crore in Q3 FY25 over Q3 ...

Shares of Natco Pharma tumbled 19.86 per cent to hit a low of Rs 975. The stock saw high trading volume on BSE today.

The stock market opened in the green on Thursday, February 13, 2025, as healthcare and pharmaceutical stocks rose. This comes ...

Blackstone, Brookfield and Warburg Pincus are in discussion to buy a majority stake in generic injectables maker Gland Pharma ...

A bill that would subject pharmacy benefit managers to licensing by the state Department of Insurance faces a hurdle: Gov. Newsom.

At 10 AM, the BSE Sensex was higher by 415 points, or 0.55 per cent, at 76,586.25, and the Nifty 50 was at 23,176.25, ahead ...

These populist policies are right at home in progressive circles, yet they are associated with the eclectic Cabinet nominees ...

EST Recursion Pharmaceuticals (RXRX) files automatic mixed securities shelfMaximize Your Portfolio with Data Driven Insights:Leverage the ...

COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results ...